Effect of Pioglitazone on Cardiometabolic Risk in Patients With Obstructive Sleep Apnea

MLA

Shiming Xu, et al. “Effect of Pioglitazone on Cardiometabolic Risk in Patients With Obstructive Sleep Apnea.” The American Journal of Cardiology, vol. 119, Apr. 2017, pp. 1205–10. EBSCOhost, https://doi.org/10.1016/j.amjcard.2016.12.034.

APA

Shiming Xu, Clete A. Kushida, James Cardell, Hafasa Mojaddidi, Philip S. Tsao, Cindy Lamendola, Alice Y.-C. Liu, Danit Ariel, Vanessa Tomasso, Sun H. Kim, Fahim Abbasi, Shailja Patel, Kaylene Grove, & Gerald M. Reaven. (2017). Effect of Pioglitazone on Cardiometabolic Risk in Patients With Obstructive Sleep Apnea. The American Journal of Cardiology, 119, 1205–1210. https://doi.org/10.1016/j.amjcard.2016.12.034

Chicago

Shiming Xu, Clete A. Kushida, James Cardell, Hafasa Mojaddidi, Philip S. Tsao, Cindy Lamendola, Alice Y.-C. Liu, et al. 2017. “Effect of Pioglitazone on Cardiometabolic Risk in Patients With Obstructive Sleep Apnea.” The American Journal of Cardiology 119 (April): 1205–10. doi:10.1016/j.amjcard.2016.12.034.